期刊文献+

基因多态性与药物不良反应相关性研究进展 被引量:3

Research progress in correlation between genetic polymorphism and adverse drug reactions
原文传递
导出
摘要 检索2009至2013年PubMed、Nature数据库、ScienceDirect数据库和中国期刊全文数据库,收集基因多态性与药物不良反应(ADR)相关性研究的期刊文献进行资料提取和分析,就药物代谢酶、转运蛋白、免疫分子、受体的基因多态性与ADR发生的关系进行综述.药物代谢酶主要涉及细胞色素P450 2C9、N-乙酰基转移酶2、尿苷二磷酸葡萄糖醛酸转移酶1A6、亚甲基四氢叶酸还原酶、基质金属蛋白酶9和二氢嘧啶脱氢酶;转运蛋白主要涉及水溶性载体家族22成员2、电压依赖性钙通道γ亚基6、水溶性载体家族6成员12、ATP结合盒转运体B1;免疫分子主要涉及人类白细胞抗原(human lymphocyte antigen,HLA)相关的基因复合体,包括HLA-B、HLA-A和HLA-C;受体主要涉及多巴胺2受体/含锚蛋白重复和激酶域1 Taq IA基因、趋化因子受体3、孤儿核受体NR4A1、孕烷X受体和白细胞介素4受体α.了解基因多态性与ADR的关系有助于实施个体化用药,避免或减少ADR的发生. PubMed,Nature database,ScienceDirect database and China National Knowledge Infrastructure (from year 2009 to 2013) were searched.The journal articles on correlation between gene polymorphism and adverse drug reactions were collected and analyzed.This article reviews the articles on correlation between adverse drug reactions and pleomorphic gene of metabolic enzymes,transporters,immune molecule and receptors.The metabolic enzymes mainly included cytochrome P450 2C9,N-acetyltransferase 2,uridine diphosphate glucuronosyl transferase 1A6,methylenetetrahydrofolate reductase,matrix metalloproteinase-9 and dihydropyrimidine dehydrogenase.The transporters mainly included solute carrier family 22 member 2,calcium channel,voltage-dependent,gamma subunit 6,solute carrier family 6 member 12,and ATP-binding cassette B1.The immune molecules mainly included human lymphocyte antigen (HLA) for instance HLA-B,HLA-A and HLA-C.The receptors mainly included dopamine 2 receptors/ankyrin repeat and kinase domain containing 1 Taq IA,chemokine receptor 3,orphan nuclear receptor NR4A1,pregnane X receptor and interleukin-4-receptor alpha.Understanding the relationship between gene polymorphism and adverse drug reactions is helpful to facilitate individualized drug administration and avoid or reduce the occurrence of adverse reactions.
出处 《药物不良反应杂志》 CSCD 2015年第1期49-53,共5页 Adverse Drug Reactions Journal
关键词 多态现象 遗传 药物相关的副作用和不良反应 个体化医学 Polymorphism,genetic Drug-related side effects and adverse reactions Individualized medicine
  • 相关文献

参考文献48

  • 1Alomar MJ. Factors affecting the development of adverse drug re- actions (Review article)[J]. Saudi Pharm J, 2014, 22(2): 83- 94.
  • 2Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventa- bility of adverse drug events among older persons in the ambulatory setting[J]. JAMA, 2003, 289(9): 1107-1116.
  • 3Pirmohamed M, Park BK. Genetic susceptibility to adverse drug reactions[J]. Trends Pharmacol Sci, 2001, 22(6) : 298-305.
  • 4Meyer UA, Phm~acogenetics and adverse drug reactions [ J ]. Lancet, 2000, 356(9242) : 1667-1671.
  • 5田月洁,李泮海,李旸.基因多态性对药品不良反应影响的研究进展[J].中国药物警戒,2009,6(12):741-745. 被引量:5
  • 6Edwards IR, Aronson JK. Adverse drag reactions : definitions, di- agnosis, and management [J]. Lancet, 2000, 356 (9237) : 1255- 1259.
  • 7Depondt C, Godard P, Espel RS, et al. A candidate gene study of antiepileptic drug tolerability and efficacy identifies an association of CYP2C9 variants with phenytoin toxieity[J]. Eur J Neurol, 2011, 18(9): 1159-1164.
  • 8Gupta VH, Amarapurkar DN, Singh M, et al. Association of N- aeetyltransferase 2 and cytoehrome P450 2El gene polymorphisms with antitubereulosis drug-induced hepatotoxicity in Western India [J]. J Gastroenterol Hepatol, 2013, 28(8) : 1368-1374.
  • 9郝金奇,陈怡,李世明,张朋,余艳琴,唐桂钰,冯福民.尿苷二磷酸葡萄糖醛酸转移酶1A6基因多态性与抗结核药致肝损害的相关性[J].中华肝脏病杂志,2011,19(3):201-204. 被引量:11
  • 10Liu SG, Li ZG, Cui L, et al. Effects of methylenetetrahydroiblate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population [ J ]. Leuk Lymphoma, 2011, 52 (6) : 1030-1040.

二级参考文献37

  • 1程书权.抗结核药物致肝损害172例临床分析[J].中华肝脏病杂志,2004,12(9):571-571. 被引量:31
  • 2蔡卫民.药物不良反应遗传背景与个体化合理用药[J].中国处方药,2005,4(4):10-15. 被引量:10
  • 3蒋益,薛战雄,郑君杰,夏宣平,王文星,陈浩,林李淼.N-乙酰基转移酶2基因型多态性与柳氮磺胺吡啶治疗炎症性肠病所产生不良反应的关系[J].中国临床药学杂志,2006,15(4):223-226. 被引量:11
  • 4Rieder M J, Reiner A P, Gage B F,et al. Effect of VKORC1 haplotypes on transcriptional regulationand warfarin dose[J]. N Eng J Med, 2005,352( 22 ):2285-2293.
  • 5Mallal S,Nolan D, Witt C,et al. Association between presence of HLA-B^*5701,HLA-DR7, and LSA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir[J]. Lancet, 2002,359( 9308 ) :727-732.
  • 6Kim S K, Jun J B, E1-Sohemy A, et al. Cost-effectiveness analysis of MTHFR polymorphism screening by polymerase chain reaction in Korean patients with rheumatoid arthritis receiving methotrexate[J]. J Rheumatol,2006,33(7): 1266-1274.
  • 7Imanishi H, Okamura N. Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma[J] J Hum Genet, 2007,52(2): 166-171.
  • 8Tsuchiya N. Drug related genetic polymorphisms affecting adverse reactions to methotrexate, vinblastine, doxorubicin and cisplatin in patients with urothelial cancer[J]. J Urol, 2008,180 (6):2389-2395.
  • 9Hirota T, Ieiri I , Takane H, et al . sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy[J]. Drug Metab Dispos, 2003, 31(5) : 677-680.
  • 10Skarke C, Dari mont J, Schmidt H, et al. Analgesic effects of cytomorphine and morphine-6- glucuronide in a transcutaneous hydromorelectrical pain model in healthy volunteers[J]. Clin Phar macol, Ther,2003, 73( 1 ):107-121.

共引文献19

同被引文献6

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部